Krystal Biotech Files 8-K
Ticker: KRYS · Form: 8-K · Filed: Feb 28, 2025 · CIK: 1711279
| Field | Detail |
|---|---|
| Company | Krystal Biotech, Inc. (KRYS) |
| Form Type | 8-K |
| Filed Date | Feb 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, exhibits
TL;DR
Krystal Biotech filed a routine 8-K on Feb 28, 2025, mostly exhibits.
AI Summary
Krystal Biotech, Inc. filed an 8-K on February 28, 2025, reporting financial statements and exhibits. The filing does not contain specific financial figures or material events beyond the standard reporting of exhibits.
Why It Matters
This filing indicates Krystal Biotech is adhering to its reporting obligations with the SEC, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing of exhibits and does not appear to contain any new material information or significant events.
Key Players & Entities
- Krystal Biotech, Inc. (company) — Registrant
- February 28, 2025 (date) — Date of Report
- Pittsburgh, Pennsylvania (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report financial statements and exhibits as of February 28, 2025.
What is the exact name of the registrant?
The exact name of the registrant is Krystal Biotech, Inc.
In which state was Krystal Biotech, Inc. incorporated?
Krystal Biotech, Inc. was incorporated in Delaware.
What is the business address of Krystal Biotech, Inc.?
The business address of Krystal Biotech, Inc. is 2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203.
What is the SIC code for Krystal Biotech, Inc.?
The Standard Industrial Classification (SIC) code for Krystal Biotech, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on February 28, 2025 regarding Krystal Biotech, Inc. (KRYS).